OneMedNet Corporation Outlines 2026 Growth Strategy With Planned Launch of AI-Driven Multimodal Subscription Platform and Enhanced Data Analytics Through Palantir Integration

OneMedNet Corporation has announced its 2026 growth strategy, which includes launching an AI-driven multimodal subscription platform and enhancing data analytics through Palantir integration. The company aims to advance its platform, support its workforce, and drive growth by leveraging Palantir's AI platform to develop its regulatory-grade, AI-ready Real-World Data network. The strategy focuses on improving access to healthcare data for life sciences organizations and reducing time to market for new drugs, medical devices, and healthcare AI solutions.

OneMedNet Showcases Strong Growth and Industry Interest at RSNA 2025

OneMedNet Corporation showcased strong growth and industry interest at the RSNA 2025 Annual Meeting. Hospitals, imaging centers, and life sciences innovators expressed significant interest in joining the OneMedNet Network and utilizing its updated iRWD™ platform. The company emphasized increased demand for high-quality, regulatory-grade real-world data and opportunities for providers to generate revenue through compliant data sharing.

OneMedNet Reports Strong Momentum and Industry Excitement at RSNA | ONMD Stock News

OneMedNet Corporation reported significant engagement and commercial traction at the RSNA 2025 event. Hospitals and life sciences innovators showed strong interest in joining OneMedNet's network and utilizing its iRWD™ platform, powered by Palantir Foundry. The event validated OneMedNet's strategy amid rising demand for regulatory-grade Real-World Data. Healthcare providers expressed interest in partnering for clinical data asset value, while life sciences companies and AI developers were keen on the platform's capabilities. The company aims to deliver global regulatory-grade RWD, supporting faster insights and better outcomes.

OneMedNet Corp shares are trading higher after recent form4 fillings showed multiple insider transactions.

OneMedNet (NASDAQ:ONMD) Insider Jeffrey Yu Purchases 15,000 Shares

OneMedNet (NASDAQ:ONMD) insider Jeffrey Yu purchased 15,000 shares at $0.77 per share, totaling $11,550. Post-transaction, Yu owns 6,768,910 shares valued at $5,212,060.70. This 0.22% position increase was disclosed in an SEC filing. Yu has made multiple recent purchases, including 24,319 shares at $0.85 each. OneMedNet's stock traded down 2.7% to $1.42. The company reported a quarterly EPS of ($0.01) and revenue of $0.18 million. Institutional investors own 0.95% of the stock. Analysts have mixed ratings on ONMD.